Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Nov;40(11):1793-1801.
doi: 10.1007/s00296-020-04680-8. Epub 2020 Aug 19.

Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry

Ozgur Akgul  1 , Hatice Bodur  2 , Sebnem Ataman  3 , Fatma Gul Yurdakul  2 , Erhan Capkin  4 , Gulcan Gurer  5 , Ilhan Sezer  6 , Mehmet Tuncay Duruoz  7 , Meltem Alkan Melikoglu  8 , Hasan Fatih Cay  9 , Aylin Rezvani  10 , Ilker Yagci  11 , Feride Gogus  12 , Ayhan Kamanli  13 , Remzi Cevik  14
Affiliations
Observational Study

Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry

Ozgur Akgul et al. Rheumatol Int. 2020 Nov.

Abstract

The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) is used as a new instrument in measuring the function, disability and health of patients with spondyloarthritis (SpA). However, the real-world evidence of ASAS HI is very limited. In the present study, our objective is to evaluate the psychometric properties and performance of ASAS HI in the real-world setting as well as comparing ASAS HI with the current instruments to assess the construct validity and determine the cut-off points in patients with both ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). A total of 991 patients with axSpA who fulfilled either the ASAS classification criteria for axial SpA (axSpA) or the Modified New York Criteria (mNY) for AS were recruited from the Biologic and targeted Synthetic antirheumatic drugs Registry (BioStaR) SpA. The construct validity of ASAS HI against the Bath Ankylosing Spondylitis Disease Activities Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein (ASDAS-CRP) the Bath Ankylosing Spondylitis Functional index (BASFI) was performed. Using the receiver operating characteristic (ROC) curves analysis, the cut-off points were calculated. Of all the recruited patients, 851 (85.9%) were AS and 140 (14.1%) were nr-axSpA. The difference in the mean ASAS HI scores of the patients with AS and the ones with nr-axSpA were not statistically significant (6.12 ± 4.29 and 6.42 ± 4.86, respectively). The mean ASAS HI score was significantly higher in females and small city residents. The ASAS HI had a strong construct validity against ASDAS-CRP, BASDAI and BASFI. A cut-off point of ≤ 4 was determined to discriminate good and moderate, as well as ≥ 12 to discriminate moderate and poor health status. In conclusion, ASAS HI is a reliable instrument to evaluate health and functioning for both patients with AS and nr-axSpA in clinical practice.

Keywords: Ankylosing spondylitis; Functional performance; Health Status Index; Health-related quality of life.

PubMed Disclaimer

References

    1. Akgul O, Ozgocmen S (2011) Classification criteria for spondyloarthropathies. World J Orthop 2(12):107–115. https://doi.org/10.5312/wjo.v2.i12.07 - DOI - PMC - PubMed
    1. Boonen A, Sieper J, van der Heijde D, Dougados M, Bukowski JF, Valluri S, Vlahos B, Kotak S (2015) The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum 44(5):556–562. https://doi.org/10.1016/j.semarthrit.2014 - DOI
    1. Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, Clegg DO, Colbert RA, Gensler LS, van der Heijde D, van der Horst-Bruinsma IE, Inman RD, Maksymowych WP, Mease PJ, Raychaudhuri S, Reimold A, Rudwaleit M, Sieper J, Weisman MH, Landewé RB (2014) The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration’s comments and concerns. Arthritis Rheumatol 66(10):2649–2656. https://doi.org/10.1002/art.38776 - DOI
    1. Rosenbaum JT, Pisenti L, Park Y, Howard RA (2019) Insight into the quality of life of patients with ankylosing spondylitis: real-world data from a us-based life impact survey. Rheumatol Ther 6(3):353–367. https://doi.org/10.1007/s40744-019-0160-8 - DOI - PMC - PubMed
    1. Kiltz U, Braun J (2020) Assessments of functioning in patients with axial spondyloarthritis. J Rheum Dis 27(1):22–29. https://doi.org/10.4078/jrd.2020.27.1.22 - DOI

Publication types

LinkOut - more resources